Page 195 - 16Neonatal Jaundice_compressed
P. 195

Neonatal jaundice





                         effective option. However, not all midwives do postnatal  checks.  It may be more useful to
                         consider the number of postnatal checks undertaken per day.
                         If we assume that each birth has, on average, three postnatal visits then this amounts to:

                            (690 000 × 3) ÷ 365 = 5670 postnatal visits per day
                         Community midwives would typically do 6–10 postnatal visits per day, which suggests that the
                         postnatal  workload is  managed by approximately  1000  midwives on any  given day, which
                         might suggest that the service could actually be delivered with fewer than 9200 meters.
                         In interpreting this analysis, there are a number of caveats to be considered in addition to the
                         most important ones already highlighted concerning the lack of evidence. The analysis assumes
                         that 25% of infants will require a confirmatory TSB before consideration of phototherapy. If this
                         estimate  were higher, then the total cost of the TCB  strategy  would be higher and the cost
                         threshold at  which TSB would be the preferred option would consequently be lower.  The
                         analysis also assumes that a move to more intensive testing does not  lead to increased
                         phototherapy. This might seem a counter-intuitive assumption as the efficacy of more intensive
                         testing  is  ultimately  predicated  on  not  missing  cases  that  could  benefit  from  treatment.
                         However, intervention rates may also be influenced  by  recommendations on thresholds for
                         commencing treatment, where current practice varies. In some settings this might lead to lower,
                         but more targeted, intervention than currently occurs.
                         The analysis also assumes that the varous test strategies will not differ in terms of the amount of
                         testing undertaken and the number of follow-up home visits undertaken. Of course, it is possible
                         that the convenience of TCB could lead to additional ‘downstream’ costs not considered here.

                         An important assumption in this analysis is that phototherapy rates would not change if a more
                         intensive testing strategy were adopted. This is a strong assumption in the model since we do
                         not know how many more cases of hyperbilirubinaemia would be correctly identified by  a
                         change in testing strategy.


              C.9        Conclusion

                         Based on the published limitations of visual  examination, the GDG strongly believes  that a
                         more intensive testing strategy is required in order to improve outcomes in neonatal jaundice.
                         This will require more resources but, if this reduces the incidence of kernicterus by sufficient
                         numbers, it would be cost-effective to implement in the NHS. While the analysis presented here
                         is unable to demonstrate that this would be cost-effective, it does suggest that the actual number
                         of kernicterus cases needed for more intensive testing to be cost-effective is relatively small, for
                         example 0.49 cases per year if the TCB strategy could be delivered with 1000 meters up to 1.52
                         cases per year if 9200 meters are required. This is the cut-off above which the total cost of TSB
                         strategy is cheaper than TCB. It is important to remember that these values are based on strong
                         assumptions (for the lifetime QALYs lost through kernicterus and the lifetime cost of kernicterus)
                         that are supported by the GDG but are not based on externally verifiable evidence. The number
                         of cases of kernicterus that could be prevented is the critical unknown. However, reports from
                         the USA 240  have shown a reduction of four cases per 100 000 births after the mid 1990s.
                         Determining which intensive testing strategy is cost-effective depends crucially on the number
                         of meters that would have to be purchased in order to deliver TCB. The number of community
                         midwives involved in home visits on any one day is far smaller than the total number working
                         in the  NHS  at any one time. Therefore it seems plausible that the TCB strategy could be
                         delivered with a number of transcutaneous meters that is sufficiently low to meet the threshold
                         for cost-effectiveness. However, service delivery is not within the remit of this NICE guideline
                         and local commissioners may want to opt for the strategy they believe can be delivered most
                         cost-effectively in their area.








              164
   190   191   192   193   194   195   196   197   198   199   200